The Wilms' tumor suppressor gene, WT1, encodes a transcription factor of critical importance in early kidney development. This project will examine regulation of the human WT1 gene, using DNase I hypersensitive sites as a starting point to identify cis regulatory DNA sequences and the corresponding transcriptional regulatory proteins that bind to them and are most important for WT1 expression in kidney development. This analytical approach is well recognized in developmental biology and allows antecedent transcriptional events to be uncovered. Such studies may also shed light on embryonic kidney-, kidney epithelial-, and/or podocyte-specific gene expression, and thereby suggest alternative treatments, such as gnee therapy, for acute and chronic glomerular disease.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Postdoctoral Individual National Research Service Award (F32)
Project #
1F32DK009263-01
Application #
2136326
Study Section
Special Emphasis Panel (ZRG2-BIOL-1 (01))
Program Officer
Hyde, James F
Project Start
1995-10-05
Project End
Budget Start
1995-07-01
Budget End
1996-06-30
Support Year
1
Fiscal Year
1995
Total Cost
Indirect Cost
Name
Beth Israel Deaconess Medical Center
Department
Type
DUNS #
076593722
City
Boston
State
MA
Country
United States
Zip Code
02215
Cohen, H T; Bossone, S A; Zhu, G et al. (1997) Sp1 is a critical regulator of the Wilms' tumor-1 gene. J Biol Chem 272:2901-13